Mycobacterium leprae, the rod-shaped bacterium responsible for causing leprosy, is an obligate intracellular pathogen characterized by a slow replication rate and a preference for infecting peripheral nerves and cooler body tissues.
Hyperbaric oxygen therapy may potentially enhance the immune system’s ability to combat Mycobacterium leprae by increasing oxygen levels and promoting wound healing in affected tissues.